Care seeking and treatment for hepatitis C infection in Rwanda: A qualitative study of patient experiences.


Journal

Global public health
ISSN: 1744-1706
Titre abrégé: Glob Public Health
Pays: England
ID NLM: 101256323

Informations de publication

Date de publication:
12 2020
Historique:
pubmed: 1 8 2020
medline: 19 8 2021
entrez: 1 8 2020
Statut: ppublish

Résumé

An estimated 71 million people live with hepatitis C virus (HCV) and without an effective vaccination, control efforts depend entirely on prevention, early diagnosis, and treatment with direct acting antiviral medication. The experiences of accessing care and treatment, as well as how HCV is locally perceived, are context specific and require an understanding of local epidemics. The objectives of this study were to explore the experiences and demand-side barriers for people with chronic HCV infection, as well as describe the social and cultural landscapes in which they experienced, managed, and perceived HCV in Rwanda. Eleven participants provided consent to participate and all completed two semi-structured interviews during treatment within a clinical trial. We identified four themes: (1) diagnosis and use of traditional medicine, (2) access and financial barriers, (3) complex social networks (4) proactivity in care-seeking. Results demonstrate the complex ways in which Rwandans understand HCV, utilise parallel health systems, activate social networks, and the importance of active agency in the opportunities and outcomes for their own health in the context of an early response to a major epidemic. Without recognising communities' understanding and expectations, it is impossible to build a sustainable and successful public health response to HCV.

Identifiants

pubmed: 32735478
doi: 10.1080/17441692.2020.1801787
doi:

Substances chimiques

Antiviral Agents 0

Types de publication

Clinical Trial Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1778-1788

Auteurs

Jennifer Ilo Van Nuil (JI)

Partners in Health, Rwinkwavu, Rwanda.

Fabienne Shumbusho (F)

Partners in Health, Rwinkwavu, Rwanda.

Fredrick Kateera (F)

Partners in Health, Rwinkwavu, Rwanda.

Alain Mukuralinda (A)

Partners in Health, Rwinkwavu, Rwanda.

Jules Kabahizi (J)

Rwanda Military Hospital, Kanombe, Rwanda.

Claude Mambo Muvunyi (CM)

College of Medicine and Health Sciences, University of Rwanda, Kigali, Rwanda.

Emmanuel Musabeyezu (E)

College of Medicine and Health Sciences, University of Rwanda, Kigali, Rwanda.

Constance Mukabatsinda (C)

College of Medicine and Health Sciences, University of Rwanda, Kigali, Rwanda.

Aimable Mbituyumuremi (A)

Rwanda Biomedical Center, Kigali, Rwanda.

Sabin Nsanzimana (S)

Rwanda Biomedical Center, Kigali, Rwanda.

Joia Mukerjee (J)

Partners in Health, Rwinkwavu, Rwanda.
Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA.
Division of Global Health Equity, Brigham and Women's Hospital, Boston, MA, USA.

Neil Gupta (N)

Partners in Health, Rwinkwavu, Rwanda.
Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA.
Division of Global Health Equity, Brigham and Women's Hospital, Boston, MA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH